SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Babylon Holdings Ltd. – ‘F-1’ on 11/9/21 – ‘EX-4.6’

On:  Tuesday, 11/9/21, at 4:07pm ET   ·   Accession #:  1193125-21-324433   ·   File #:  333-260911

Previous ‘F-1’:  None   ·   Next & Latest:  ‘F-1’ on 4/29/22   ·   13 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/09/21  Babylon Holdings Ltd.             F-1                  154:23M                                    Donnelley … Solutions/FA

Registration Statement by a Foreign Issuer   —   Form F-1

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-1         Registration Statement by a Foreign Issuer          HTML   4.20M 
 2: EX-4.5      Instrument Defining the Rights of Security Holders  HTML    176K 
 3: EX-4.6      Instrument Defining the Rights of Security Holders  HTML    188K 
 4: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     73K 
 5: EX-5.1      Opinion of Counsel re: Legality                     HTML     58K 
 6: EX-21.1     Subsidiaries List                                   HTML     40K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     40K 
 8: EX-23.2     Consent of Expert or Counsel                        HTML     40K 
 9: EX-23.3     Consent of Expert or Counsel                        HTML     40K 
16: R1          Cover Page                                          HTML     52K 
17: R2          Consolidated Statement of Profit and Loss and       HTML    112K 
                Other Comprehensive Loss                                         
18: R3          Consolidated Statement of Profit and Loss and       HTML     47K 
                Other Comprehensive Loss (Parenthetical)                         
19: R4          Consolidated Statement of Financial Position        HTML    141K 
20: R5          Consolidated Statement of Changes in Equity         HTML     82K 
21: R6          Consolidated Statement of Cash Flows                HTML    144K 
22: R7          Corporate information                               HTML     48K 
23: R8          Basis of preparation                                HTML     77K 
24: R9          Significant accounting judgements, estimates and    HTML     52K 
                assumptions                                                      
25: R10         Business Acquisitions                               HTML     92K 
26: R11         Disposals of Subsidiaries                           HTML     62K 
27: R12         Accounting policies                                 HTML    137K 
28: R13         Revenue                                             HTML    107K 
29: R14         Segment Information                                 HTML    268K 
30: R15         Employee Benefits Expense                           HTML     63K 
31: R16         Platform & Application Expenses                     HTML     57K 
32: R17         Research and Development Expenses                   HTML     54K 
33: R18         Sales, General and Administrative expenses          HTML     64K 
34: R19         Finance income and costs                            HTML     63K 
35: R20         Taxation                                            HTML     69K 
36: R21         Property, Plant and Equipment                       HTML     94K 
37: R22         Intangible Assets and Goodwill                      HTML    262K 
38: R23         Investments in Subsidiaries and Associates          HTML    145K 
39: R24         Trade and Other Receivables, Prepayments and        HTML     63K 
                Contract Assets                                                  
40: R25         Trade and Other Payables, Accruals and Provisions   HTML     54K 
41: R26         Deferred Grant Income -- Tax Credit                 HTML     55K 
42: R27         Claims Payable                                      HTML     54K 
43: R28         Cash and Cash Equivalents                           HTML     61K 
44: R29         Leases                                              HTML    102K 
45: R30         Loans and borrowings                                HTML     70K 
46: R31         Employee Benefits                                   HTML     73K 
47: R32         Capital and Reserves                                HTML    137K 
48: R33         Summary of Significant Accounting Policies          HTML    137K 
49: R34         Related Parties                                     HTML     48K 
50: R35         Financial Risk Management Objectives and Policies   HTML     82K 
51: R36         Loss Per Share                                      HTML     52K 
52: R37         Assets and Liabilities Classified as Held for Sale  HTML     57K 
53: R38         Adoption of New and Revised International           HTML     47K 
                Reporting Standards                                              
54: R39         Subsequent Events                                   HTML     52K 
55: R40         Summary of Significant Accounting Policies          HTML    235K 
                (Policies)                                                       
56: R41         Business Acquisitions (Tables)                      HTML     79K 
57: R42         Accounting policies (Tables)                        HTML     51K 
58: R43         Revenue (Tables)                                    HTML    107K 
59: R44         Disposals of Subsidiaries (Tables)                  HTML     61K 
60: R45         Segment Information (Tables)                        HTML    267K 
61: R46         Employee Benefits Expense (Tables)                  HTML     62K 
62: R47         Platform & Application Expenses (Tables)            HTML     56K 
63: R48         Research and Development Expenses (Tables)          HTML     53K 
64: R49         Sales, General and Administrative expenses          HTML     63K 
                (Tables)                                                         
65: R50         Finance income and costs (Tables)                   HTML     61K 
66: R51         Taxation (Tables)                                   HTML     67K 
67: R52         Property, Plant and Equipment (Tables)              HTML     93K 
68: R53         Intangible Assets and Goodwill (Tables)             HTML    253K 
69: R54         Investments in Subsidiaries and Associates          HTML    140K 
                (Tables)                                                         
70: R55         Trade and Other Receivables, Prepayments and        HTML     64K 
                Contract Assets (Tables)                                         
71: R56         Trade and Other Payables, Accruals and Provisions   HTML     53K 
                (Tables)                                                         
72: R57         Deferred Grant Income -- Tax Credit (Tables)        HTML     54K 
73: R58         Claims Payable (Tables)                             HTML     53K 
74: R59         Cash and Cash Equivalents (Tables)                  HTML     58K 
75: R60         Leases (Tables)                                     HTML    102K 
76: R61         Loans and borrowings (Tables)                       HTML     61K 
77: R62         Employee Benefits (Tables)                          HTML     66K 
78: R63         Capital and Reserves (Tables)                       HTML    109K 
79: R64         Financial Risk Management Objectives and Policies   HTML     68K 
                (Tables)                                                         
80: R65         Loss Per Share (Tables)                             HTML     51K 
81: R66         Assets and Liabilities Classified as Held for Sale  HTML     55K 
                (Tables)                                                         
82: R67         Basis of preparation - Additional Information       HTML     65K 
                (Detail)                                                         
83: R68         Business Acquisitions - Summary of Aggregate        HTML     75K 
                Purchase Price of the Acquisition has been                       
                Allocated on a Preliminary Basis (Detail)                        
84: R69         Business Acquisitions - Additional Information      HTML    118K 
                (Detail)                                                         
85: R70         Business Acquisitions - Summary of Estimated Fair   HTML     57K 
                Value of Assets (Detail)                                         
86: R71         Business Acquisitions - Summary of Effect of        HTML     62K 
                Acquisition (Detail)                                             
87: R72         Significant accounting judgements, estimates and    HTML     45K 
                assumptions - Additional Information (Detail)                    
88: R73         Disposals of Subsidiaries - Schedule of Disposal    HTML     78K 
                of Subsidiaries (Detail)                                         
89: R74         Disposals of Subsidiaries - Additional Information  HTML     48K 
                (Detail)                                                         
90: R75         Accounting policies - Additional Information        HTML     54K 
                (Detail)                                                         
91: R76         Accounting policies - Summary of Property, Plant    HTML     47K 
                and Equipment (Detail)                                           
92: R77         Accounting policies - Summary of Useful Lives of    HTML     55K 
                the Group's Intangible Assets (Detail)                           
93: R78         Revenue - Summary of Disaggregation of Revenue      HTML     52K 
                (Detail)                                                         
94: R79         Revenue - Summary of Information about              HTML     49K 
                Receivables, Contract Assets and Contract                        
                Liabilities from Contracts with Customers (Detail)               
95: R80         Revenue - Summary of Transaction Price Allocated    HTML     57K 
                to the Remaining Performance Obligations (Detail)                
96: R81         Revenue - Summary of Significant Changes in         HTML     49K 
                Contract Liabilities (Detail)                                    
97: R82         Revenue - Additional Information (Detail)           HTML     43K 
98: R83         Segment Information - Summary of Segments and       HTML    101K 
                Reconciliation Operations as per Segment                         
                Information (Detail)                                             
99: R84         Segment Information - Summary of Revenue Derived    HTML     74K 
                from Major Customers (Detail)                                    
100: R85         Segment Information - Summary of Revenue from       HTML     61K  
                External Customers (Detail)                                      
101: R86         Segment Information - Additional Information        HTML     56K  
                (Detail)                                                         
102: R87         Employee Benefits Expense - Additional Information  HTML     52K  
                (Detail)                                                         
103: R88         Employee benefits expense - Summary of Employee     HTML     50K  
                Benefits Expense (Detail)                                        
104: R89         Employee benefits expense - Summary of Average      HTML     53K  
                Staff Numbers (Detail)                                           
105: R90         Platform & Application Expenses - Summary of        HTML     67K  
                Platform & Application Expenses (Detail)                         
106: R91         Research and Development Expenses - Summary of      HTML     54K  
                Research and Development Expenses (Detail)                       
107: R92         Sales, General and Administrative expenses -        HTML     71K  
                Summary of Sales, General and Administrative                     
                Expenses (Detail)                                                
108: R93         Finance income and costs - Summary of Finance       HTML     55K  
                Costs (Detail)                                                   
109: R94         Taxation - Summary of Components of Income Tax      HTML     50K  
                (Detail)                                                         
110: R95         Taxation - Schedule of Reconciliation of Income     HTML     64K  
                Tax Expense Benefit (Detail)                                     
111: R96         Taxation - Schedule of Reconciliation of Income     HTML     43K  
                Tax Expense Benefit (Parenthetical) (Detail)                     
112: R97         Taxation - Additional Information (Detail)          HTML     56K  
113: R98         Property, Plant and Equipment - Schedule of         HTML     74K  
                Property Plant and Equipment (Detail)                            
114: R99         Intangible Assets and Goodwill - Additional         HTML     96K  
                Information (Detail)                                             
115: R100        Intangible Assets and Goodwill - Schedule of        HTML    123K  
                Reconciliation of Changes in Intangible Assets and               
                Goodwill (Detail)                                                
116: R101        Investments in Subsidiaries and Associates -        HTML    172K  
                Schedule of Investments in Subsidiaries, Groups                  
                and Associates (Detail)                                          
117: R102        Investments in Subsidiaries and Associates -        HTML     76K  
                Additional Information (Detail)                                  
118: R103        Investments in Subsidiaries and Associates -        HTML     71K  
                Summary of Financial Information of Associate                    
                (Detail)                                                         
119: R104        Investments in Subsidiaries and Associates -        HTML     66K  
                Summary of Financial Data for the Subsidiary                     
                Included in the Interim Financial Statements                     
                (Detail)                                                         
120: R105        Trade and Other Receivables, Prepayments and        HTML     54K  
                Contract Assets - Summary of Trade and Other                     
                Receivables, Prepayments and Contract Assets                     
                (Detail)                                                         
121: R106        Trade and Other Receivables, Prepayments and        HTML     46K  
                Contract Assets - Additional Information (Detail)                
122: R107        Trade and Other Receivables, Prepayments and        HTML     49K  
                Contract Assets - Summary of Significant Changes                 
                in Contract Assets (Detail)                                      
123: R108        Trade and Other Payables, Accruals and Provisions   HTML     53K  
                - Summary of Trade and Other Payables, Accruals                  
                and Provisions (Detail)                                          
124: R109        Deferred Grant Income -- Tax Credit - Schedule of   HTML     51K  
                Deferred Grant Income (Detail)                                   
125: R110        Claims Payable - Summary of Detailed Information    HTML     52K  
                about Liability for Unpaid Claims and Claims                     
                Adjustment Expense (Detail)                                      
126: R111        Cash and Cash Equivalents - Summary of Detailed     HTML     51K  
                Information about Cash and Cash Equivalents                      
                (Detail)                                                         
127: R112        Leases - Additional Information (Detail)            HTML     51K  
128: R113        Leases - Summary of Right-of-use Assets and Lease   HTML     72K  
                Liabilities Regarding Building Lease (Detail)                    
129: R114        Leases - Summary of Amounts have been Recognized    HTML     50K  
                in the Consolidated Statement of Profit and Loss                 
                (Detail)                                                         
130: R115        Leases - Summary of Undiscounted Maturities of      HTML     49K  
                Lease Liabilities (Detail)                                       
131: R116        Loans and borrowings - Additional Information       HTML     75K  
                (Detail)                                                         
132: R117        Loans and borrowings - Summary of financing cash    HTML     50K  
                flows (Detail)                                                   
133: R118        Employee Benefits - Additional Information          HTML    111K  
                (Detail)                                                         
134: R119        Employee Benefits - Summary of Number and Weighted  HTML     67K  
                Average Exercise Price of Share Options (Detail)                 
135: R120        Employee Benefits - Summary of Share-based Payment  HTML     44K  
                Expense (Detail)                                                 
136: R121        Capital and Reserves - Summary of Share Capital     HTML     67K  
                (Detail)                                                         
137: R122        Capital and Reserves - Summary of Authorized        HTML     60K  
                Called Up and Fully Paid Up Capital (Detail)                     
138: R123        Capital and Reserves - Summary of Authorized        HTML     63K  
                Called Up and Fully Paid Up Capital                              
                (Parenthetical) (Detail)                                         
139: R124        Capital and Reserves - Summary of Other             HTML     47K  
                Comprehensive Income Accumulated in Reserves, Net                
                of Tax (Detail)                                                  
140: R125        Capital and Reserves - Additional Information       HTML    111K  
                (Detail)                                                         
141: R126        Related Parties - Additional Information (Detail)   HTML     48K  
142: R127        Financial Risk Management Objectives and Policies   HTML     51K  
                - Additional Information (Detail)                                
143: R128        Financial Risk Management Objectives and Policies   HTML     56K  
                - Summary of Significant Exchange Rates (Detail)                 
144: R129        Financial Risk Management Objectives and Policies   HTML     52K  
                - Summary of Foreign Currency Sensitivity (Detail)               
145: R130        Financial Risk Management Objectives and Policies   HTML     46K  
                - Summary of Foreign Currency Sensitivity                        
                (Parenthetical) (Detail)                                         
146: R131        Loss Per Share - Summary of Computation of Basic    HTML     51K  
                and Dilutive Net Loss Per Share (Detail)                         
147: R132        Loss Per Share - Additional Information (Detail)    HTML     43K  
148: R133        Assets and Liabilities Classified as Held for Sale  HTML     74K  
                - Summary of Major Classes of Assets and                         
                Liabilities been Classified as Held for Sale                     
                (Detail)                                                         
149: R134        Assets and Liabilities Classified as Held for Sale  HTML     52K  
                - Additional Information (Detail)                                
150: R135        Subsequent Events - Additional Information          HTML    107K  
                (Detail)                                                         
152: XML         IDEA XML File -- Filing Summary                      XML    293K  
15: XML         XBRL Instance -- d225015df1_htm                      XML   4.93M 
151: EXCEL       IDEA Workbook of Financial Reports                  XLSX    212K  
11: EX-101.CAL  XBRL Calculations -- bbln-20210630_cal               XML    240K 
12: EX-101.DEF  XBRL Definitions -- bbln-20210630_def                XML   1.13M 
13: EX-101.LAB  XBRL Labels -- bbln-20210630_lab                     XML   1.99M 
14: EX-101.PRE  XBRL Presentations -- bbln-20210630_pre              XML   1.62M 
10: EX-101.SCH  XBRL Schema -- bbln-20210630                         XSD    445K 
153: JSON        XBRL Instance as JSON Data -- MetaLinks              552±   803K  
154: ZIP         XBRL Zipped Folder -- 0001193125-21-324433-xbrl      Zip   1.12M  


‘EX-4.6’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-4.6  

Exhibit 4.6

EXECUTION VERSION

WARRANT INSTRUMENT

4 NOVEMBER 2021

BABYLON HOLDINGS LIMITED

 

LOGO

Allen & Overy LLP

 


CONTENTS

 

Clause         Page  

1.

  

Interpretation

     1  

2.

  

Constitution, Grant and Form of Warrants and Register

     5  

3.

  

Exercise of Subscription Entitlement

     6  

4.

  

Lapse of Subscription Entitlement

     6  

5.

  

Procedures on an Exercise Event

     6  

6.

  

Issue of Warrant Shares

     8  

7.

  

Cash Redemption

     9  

8.

  

Adjustment of Subscription Entitlement

     10  

9.

  

Adjustment of Warrant Shares

     11  

10.

  

Determination by Auditors or Independent Financial Adviser

     11  

11.

  

Undertakings and Information

     13  

12.

  

Winding Up

     13  

13.

  

Transfer of Warrants

     14  

14.

  

Meetings of Warrantholders

     14  

15.

  

Warrantholders’ Representative

     14  

16.

  

Tax

     14  

17.

  

Payments

     14  

18.

  

Variation

     15  

19.

  

Severance

     15  

20.

  

Third Party Rights

     15  

21.

  

Notices

     16  

22.

  

Governing Law and Jurisdiction

     16  

23.

  

Process Agent

     16  

Schedule

  

1.

  

Initial Warrantholders

     17  

2.

  

Form of Warrant Certificate

     18  

3.

  

Form of Exercise Notice

     19  

4.

  

The Conditions

     21  

Signatories

     26  


THIS INSTRUMENT (this Instrument) is executed as a deed poll on 4 November 2021 by BABYLON HOLDINGS LIMITED, a public limited company incorporated and registered in Jersey with registered number 115471, the registered office of which is at 13 Castle Street, St Helier, Jersey, JE1 1ES (the Company).

WHEREAS:

 

(A)

The Company has entered into a note subscription agreement with the Initial Warrantholders on 8 October 2021 in connection with the issue of up to US$200,000,000 unsecured notes due 2026 (the Notes) pursuant to a notes deed poll dated on or around the date of this Instrument (the Notes Deed Poll) and the Warrants constituted by this Instrument.

 

(B)

The Warrants have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold directly or indirectly within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The issue of the Warrants is being made by the Company in a private placement transaction in a manner not requiring registration under the Securities Act.

 

(C)

The Company, by resolution of its board of directors passed on 7 October 2021, has authorised the issue of the Warrants to subscribe for the Warrant Shares on the terms set out in this Instrument, which shall take effect as a deed poll.

NOW THIS INSTRUMENT WITNESSES AND IT IS DECLARED as follows:

 

1.

INTERPRETATION

 

1.1

The definitions and rules of interpretation in this Clause apply in this Instrument.

Adjustment has the meaning given in Clause 8.1.

Affiliate means, in relation to any person, a subsidiary of that person or a holding company of that person or any other subsidiary of that holding company.

AlbaCore means AlbaCore Capital LLP, a limited liability partnership registered in England with number OC412196 and having its registered office at 55 St. James’s Street, London, SW1A 1LA.

Articles means the memorandum and articles of association of the Company as amended or superseded from time to time.

Associated Company means in relation to a Warrantholder, (a) any of its Affiliates, or any fund, partnership, special purpose vehicle or similar vehicle (the Entity) in respect of which the person or any of its Affiliates is (i) a limited partner or the general partner; or (ii) an investment manager; or (iii) directly or indirectly Controls the Entity or (b) any investor in an Entity or such person, and for the purposes of this definition, Control means in relation to any person, where a person has direct or indirect control over more than 50% of the voting share capital of the relevant person.

Auditors means the auditors of the Company from time to time.

Board means the board of directors of the Company from time to time.

Business Day means a day (other than a Saturday, Sunday or public holiday) on which commercial banks and foreign exchange markets are open for business in Dublin, London, New York and Jersey.

Cash Redemption Election has the meaning given in Clause 7.1.

 

1


Cash Redemption Payment has the meaning given in Clause 7.1.

Certificate means a certificate in respect of Warrants, substantially in the form set out in Schedule 2.

Change of Control has the meaning given in the Notes Deed Poll.

Change of Control Exercise Event has the meaning given in Clause 3.2.

Class A Ordinary Shares means the class A ordinary shares of US$0.0000422573245084686 each in the capital of the Company from time to time and, if there is a sub-division, consolidation or reclassification of such shares, the shares resulting from that event, having the rights and being subject to the restrictions set out in the Articles.

Closing Price means, in respect of a Class A Ordinary Share on any Trading Day, the closing price on such Trading Day on the Relevant Stock Exchange of a Class A Ordinary Share published by or derived from Bloomberg page HP (or any successor page) (setting Last Price, or any other successor setting and using values not adjusted for any event occurring after such Trading Day; and for the avoidance of doubt, all values will be determined with all adjustment settings on the DPDF Page, or any successor or similar setting, switched off) in respect of the Relevant Stock Exchange and in respect of such Class A Ordinary Shares, as determined by the Company, provided that if on any such Trading Day (for the purpose of this definition, the Affected Day) such price is not available or cannot otherwise be determined as provided above, the Closing Price of a Class A Ordinary Share in respect of such Trading Day shall be the Closing Price, determined as provided above, on the immediately preceding Trading Day on which the same can be so determined, and further provided that if such immediately preceding Trading Day falls prior to the fifth day before the Affected Day, an Independent Financial Adviser shall determine the Closing Price in good faith.

COBO Order means the Control of Borrowing (Jersey) Order 1958.

Conditions means the terms and conditions set out in Schedule 4 (subject to any alterations made in accordance with this Instrument).

Early Redemption Exercise Event has the meaning given in Clause 3.3.

Encumbrances means any security interests, claims, charges, mortgages, liens, options, pre-emption or other third-party rights, or agreements, arrangements or obligations to create any of the foregoing.

Equity Shares means shares in the equity share capital of the Company (or, following an Adjustment, the relevant member of the Group) from time to time.

Equivalent Proportion means a number of Warrants (rounded to the nearest whole Warrant) calculated by multiplying the total number of Warrants held by a Warrantholder by the proportion that the principal amount of the Notes being transferred by that Warrantholder bears to the total principal amount of the Notes held by that Warrantholder immediately prior to such transfer.

Exercise Completion Date has the meaning given in Clause 5.1(c).

Exercise Event means a Mandatory Exercise Event, a Change of Control Exercise Event, an Early Redemption Exercise Event and/or a Final Maturity Exercise Event.

Exercise Notice means a notice in writing in the form, or substantially in the form, set out in Schedule 3.

Exit means any Change of Control or de-listing of the Equity Shares from the New York Stock Exchange.

 

2


Final Maturity Date has the meaning given in the Notes Deed Poll.

Final Maturity Exercise Event has the meaning given in Clause 3.4.

Group means the Company, any subsidiary undertaking or any holding company of the Company and any other subsidiary undertaking from time to time of a holding company of the Company.

holding company has the meaning given in Clause 1.12.

Initial Warrantholders means the persons whose names and addresses are set out in Schedule 1.

Independent Financial Adviser means an independent financial advisory firm or an independent investment bank, in each case of international repute.

Issuer Redemption Notice has the meaning given in the Notes Deed Poll.

Law means the Companies (Jersey) Law 1991 (as amended).

Mandatory Exercise Event has the meaning given in Clause 3.1.

Notes has the meaning given in Recital (A).

Notes Deed Poll has the meaning given in Recital (A).

Permitted Transferee means a Related Fund of a Warrantholder or an Affiliate of a Warrantholder.

Redemption Date has the meaning given in the Notes Deed Poll.

Redemption Notice has the mean given in the Notes Deed Poll.

Register means a register of Warrantholders referred to in Clause 2.5, and kept and maintained in accordance with paragraph 1 of Schedule 4.

Registered Office means the registered office of the Company from time to time.

Related Fund has the meaning given in the Notes Deed Poll.

Relevant Stock Exchange means in respect of the Class A Ordinary Shares the principal stock exchange or securities market on which the Class A Ordinary Shares are listed, admitted to trading or quoted or dealt in.

Restricted Period means the period commencing on the date of this Instrument and ending on the date that is 18 calendar months from the date of this Instrument.

Subscription Entitlement has the meaning given in Clause 2.4.

Subscription Price means, subject to Clause 8, US$0.0000422573245084686 per Warrant Share.

subsidiary has the meaning given in Clause 1.12.

Tax Deduction means a withholding or deduction for or on account of, any present or future taxes, duties, assessments or governmental charges of whatever nature.

Tax Redemption Date has the meaning given in the Notes Deed Poll.

Tax Redemption Notice has the meaning given in the Notes Deed Poll.

 

3


Trading Day means a day on which the Relevant Stock Exchange is open for business and on which Class A Ordinary Shares may be dealt in (other than a day on which the Relevant Stock Exchange is scheduled to or does close prior to its regular closing time).

Transfer has the meaning given in paragraph 2.1 of Schedule 4.

Value Cap means, subject to Clause 8, US$15.00 per Class A Ordinary Share.

Value Cap Adjustment has the meaning given in subparagraph (ii) of Clause 8.1.

Value Cap Warrant Shares Adjustment means any adjustment to the number of Warrant Shares to which a Warrantholder is entitled per Warrant held by it made in accordance with Clause 9.

Warrant means a private warrant to subscribe for one Warrant Share, on the terms and subject to the conditions of this Instrument.

Warrant Shares means the Class A Ordinary Shares or, following an Adjustment, such other shares in the capital of a member of the Group as may be required pursuant to the terms of an Adjustment, in each case issued to the Warrantholder following exercise of the Warrants in accordance with the terms of this Instrument (and Warrant Share means any of them).

Warrantholder means the person or persons in whose name(s) a Warrant is registered from time to time as evidenced by the Register.

Warrantholder Consent means prior consent in writing from a Warrantholder Majority, which consent may be communicated to the Company by the Warrantholders’ Representative on behalf of the Warrantholders.

Warrantholder Majority means one or more Warrantholder(s) for the time being holding outstanding Warrants representing not less than 50% in nominal value of the Warrant Shares subject to an outstanding Subscription Entitlement.

Warrantholders’ Representative means AlbaCore or such other person as the Warrantholder Majority may appoint by giving notice to the Company.

 

1.2

Clause, Schedule and paragraph headings shall not affect the interpretation of this Instrument.

 

1.3

References to Clauses and Schedules are to the Clauses of and Schedules to this Instrument, and references to paragraphs are to paragraphs of the relevant Schedule.

 

1.4

The Schedules form part of this Instrument and shall have effect as if set out in full in the body of this Instrument. Any reference to this Instrument includes the Schedules.

 

1.5

A reference to this Instrument is a reference to this Instrument as varied or novated in accordance with its terms from time to time.

 

1.6

Unless the context otherwise requires, words in the singular shall include the plural and the plural shall include the singular.

 

1.7

Unless the context otherwise requires, a reference to one gender shall include a reference to the other genders.

 

1.8

A reference to writing or written includes e-mail.

 

4


1.9

Any words following the terms including, include, in particular, for example or any similar expression shall be construed as illustrative and shall not limit the sense of the words, description, definition, phrase or term preceding those words.

 

1.10

A reference to a statute or statutory provision is a reference to it as amended or re-enacted from time to time and shall include all subordinate legislation made from time to time under that statute or statutory provision.

 

1.11

A reference to US$, $ or US dollars shall be dollars of the United States of America.

 

1.12

A company is a subsidiary of another company (its holding company) if that other company, directly or indirectly, through one or more subsidiaries:

 

  (a)

holds a majority of the voting rights in it;

 

  (b)

is a member or shareholder of it and has the right to appoint or remove a majority of its board of directors or equivalent managing body;

 

  (c)

is a member or shareholder of it and controls alone, or pursuant to an agreement with other shareholders or members, a majority of the voting rights in it; or

 

  (d)

has the right to exercise a dominant influence over it, for example by having the right to give directions with respect to its operating and financial policies, with which directions its directors are obliged to comply.

 

2.

CONSTITUTION, GRANT AND FORM OF WARRANTS AND REGISTER

 

2.1

The Company hereby constitutes 1,757,499 Warrants to subscribe for the Warrant Shares on the terms and subject to the conditions of this Instrument.

 

2.2

The Warrants shall be issued in registered form on the date of this Instrument to the Initial Warrantholders in the respective numbers set out opposite their names in Schedule 1.

 

2.3

The Warrants shall be issued subject to the Articles and otherwise on the terms and subject to the conditions of this Instrument (including the Conditions) which are binding on the Company and each Warrantholder, and all persons claiming through or under them respectively. The Warrants shall not be issued to more than ten Warrantholders at any time without the consent of the Jersey Financial Services Commission under the COBO Order.

 

2.4

Each Warrant shall confer the right on the Warrantholder holding such Warrant to receive one Warrant Share, subject to any Adjustment or any Value Cap Adjustment in accordance with Clause 8 and to any Value Cap Warrant Shares Adjustment in accordance with Clause 9 (the Subscription Entitlement). Any Warrant Shares issued upon the exercise of the Subscription Entitlement shall be issued at the Subscription Price per Warrant Share and credited as fully paid on the terms and subject to the conditions of this Instrument. Notwithstanding the foregoing, upon an Exercise Event, the Company may at its absolute discretion elect to satisfy the Subscription Entitlement in whole or in part by making a Cash Redemption Payment in accordance with Clause 7.

 

2.5

The Company shall procure that the Register is maintained, and Certificates are issued, in accordance with the Conditions.

 

2.6

During the Restricted Period, no Warrantholder shall be permitted to enter into a hedging transaction in respect of its risk or exposure under the Warrants (except for currency management operations which are carried out in the ordinary course of business and for non-speculative purposes only).

 

5


3.

EXERCISE OF SUBSCRIPTION ENTITLEMENT

 

3.1

The Subscription Entitlement of each Warrantholder shall be deemed to be automatically and irrevocably exercised (in whole and not in part only) at 11 am (New York time) on the first date following which the Closing Price of the Class A Ordinary Shares has equalled or exceeded the Value Cap for any 20 Trading Days within any 30-Trading Day period commencing on the first Trading Day following the expiry of the Restricted Period (such date, a Mandatory Exercise Event). For the avoidance of doubt, no Mandatory Exercise Event may occur during the Restricted Period.

 

3.2

In the event that a Redemption Notice is given pursuant to the Notes Deed Poll in connection with a Change of Control, the Subscription Entitlement of each Warrantholder shall, unless agreed otherwise between the Company and the Warrantholder Majority, be deemed to be automatically and irrevocably exercised (in whole and not in part only) at 11 am (New York time) on the date of receipt by the Company of such Redemption Notice (a Change of Control Exercise Event).

 

3.3

In the event that an Issuer Redemption Notice or Tax Redemption Notice is given pursuant to the Notes Deed Poll at any time following the date of this Instrument, the Subscription Entitlement of each Warrantholder shall, unless agreed otherwise between the Company and the Warrantholder Majority, be deemed to be automatically and irrevocably exercised (in whole and not in part only) at 11 am (New York time) on the Redemption Date or Tax Redemption Date (as applicable) (an Early Redemption Exercise Event).

 

3.4

If and to the extent the Subscription Entitlement has not been exercised prior to the Final Maturity Date, the Subscription Entitlement shall, unless agreed otherwise between the Company and the Warrantholder Majority, be deemed to be automatically and irrevocably exercised (in whole and not in part only) at 11 am (New York time) on the Final Maturity Date (a Final Maturity Exercise Event).

 

4.

LAPSE OF SUBSCRIPTION ENTITLEMENT

Subject to Clause 12, if an effective resolution is passed or an order is made for the winding up of the Company (otherwise than for the purposes of a reconstruction, consolidation, amalgamation or merger on terms previously sanctioned by a Warrantholder Consent), the Subscription Entitlement and the Warrants to which they relate shall automatically lapse and cease to be exercisable on the date of that resolution or order.

 

5.

PROCEDURES ON AN EXERCISE EVENT

 

5.1

As soon as reasonably practicable following a Mandatory Exercise Event or as soon as reasonably practicable following receipt of a Redemption Notice in respect of a Change of Control, and at least ten Business Days prior to an Early Redemption Exercise Event or a Final Maturity Exercise Event, the Company shall issue an Exercise Notice to the Warrantholders’ Representative (in accordance with the provisions of Clause 21) which shall specify:

 

  (a)

in the event of a Mandatory Exercise Event or a Change of Control Exercise Event, the date and time on which the Subscription Entitlement was deemed to be automatically and irrevocably exercised in accordance with Clause 3.1 or 3.2 as applicable or, in the event of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date and time on which the Subscription Entitlement shall be deemed to be automatically and irrevocably exercised in accordance with Clause 3.3 or 3.4 as applicable;

 

  (b)

whether the Company will satisfy the Subscription Entitlement:

 

  (i)

by issuing Warrant Shares; or

 

  (ii)

by making a Cash Redemption Payment; or

 

6


  (iii)

by a combination of (i) and (ii), provided that:

 

  (A)

the proportions in which the Company satisfies the Subscription Entitlement by issuing Warrant Shares and by making a Cash Redemption Payment respectively shall be determined at the absolute discretion of the Company and shall be set out in the Exercise Notice; and

 

  (B)

an amount equal to the aggregate Subscription Price for the specified number of Warrant Shares to be issued (rounded up to the nearest US$0.01) shall be deducted from the Cash Redemption Payment in lieu of payment of the Subscription Price to the Company in cash and such deduction shall be set out in the Exercise Notice;

 

  (c)

the date on which the Company shall issue the Warrant Shares and/or make the Cash Redemption Payment (as applicable), which shall be:

 

  (i)

in respect of a Mandatory Exercise Event, a date within a period of 28 days from the Mandatory Exercise Event; or

 

  (ii)

in respect of a Change of Control Exercise Event, as soon as reasonably practicable following the Change of Control Exercise Event; or

 

  (iii)

in respect of an Early Redemption Exercise Event, the Redemption Date or Tax Redemption Date (as applicable); or

 

  (iv)

in respect of a Final Maturity Exercise Event, the Final Maturity Date,

provided that in all cases such date shall be a Business Day (and if such date is not a Business Day, the next following day that is a Business Day) (the Exercise Completion Date);

 

  (d)

where the Company is satisfying the Subscription Entitlement (in whole or in part) by issuing Warrant Shares, the number of Warrant Shares to be issued to each Warrantholder, including (where applicable), reasonable detail of any Value Cap Warrant Shares Adjustment made in accordance with Clause 9;

 

  (e)

where the Company is satisfying the Subscription Entitlement in whole or in part by making a Cash Redemption Payment, the amount of the Cash Redemption Payment to be made to each Warrantholder including reasonable detail of the calculation of such Cash Redemption Payment; and

 

  (f)

where applicable, reasonable detail of the basis of determination and/or calculation of the Closing Price.

 

5.2

Promptly (and in any event within 10 Business Days or, if earlier, at least 2 Business Days prior to the Exercise Completion Date) following receipt of the Exercise Notice by the Warrantholders’ Representative, each Warrantholder shall:

 

  (a)

deliver to the Company at its Registered Office any Certificate(s) issued by the Company in respect of the Warrants held by such Warrantholder (or deed of indemnity in favour of the Company on such terms as the Company may reasonably require in the case of any lost, damaged or destroyed Certificates);

 

  (b)

where the Company is satisfying the Subscription Entitlement in whole by issuing Warrant Shares pursuant to Clause 5.1(b)(i), pay to the Company (or procure payment to the Company of) the aggregate Subscription Price applicable to the Warrant Shares to be issued to it as specified in the Exercise Notice in US dollars in accordance with Clause 17; and

 

7


  (c)

where the Company is satisfying the Subscription Entitlement in whole or in part by making a Cash Redemption Payment, notify the Company of its account details for the making of the Cash Redemption Payment in accordance with Clause 17.3.

 

5.3

Once delivered, an Exercise Notice shall be irrevocable (except with the consent of the Warrantholder Majority, which consent may be withheld or conditioned in the Warrantholder Majority’s absolute discretion).

 

5.4

Where the Exercise Notice specifies that the Company is satisfying the Subscription Entitlement (in whole or in part) by issuing Warrant Shares, on the Exercise Completion Date, each Warrantholder shall be deemed to subscribe for such Warrant Shares at the Subscription Price per Warrant Share, which shall be issued to the Warrantholder by the Company free from any Encumbrances (save as set out in the Articles) and credited by the Company as being fully paid.

 

6.

ISSUE OF WARRANT SHARES

 

6.1

Subject to the Articles, to any applicable legal and regulatory requirements and to compliance by the relevant Warrantholder(s) with the provisions of Clause 5.2, completion of the allotment and issue of Warrant Shares shall take place on the Exercise Completion Date or at such earlier time as the Board may determine (acting in its absolute discretion).

 

6.2

On the Exercise Completion Date, the Company shall promptly, subject to the Law and to the Articles and the Warrantholder’s compliance with its applicable obligations in Clause 5.2:

 

  (a)

allot and issue to the Warrantholder the number of Warrant Shares in respect of which its Subscription Entitlement has been exercised;

 

  (b)

procure the entry of the Warrantholder in the Company’s register of members as the holder of the number of Warrant Shares issued to it and deliver a copy thereof to the Warrantholder; and

 

  (c)

to the extent that the Warrant Shares are to be held in certificated form, deliver to the Warrantholder a duly executed share certificate for the number of Warrant Shares issued to it that will be so held.

 

6.3

The Warrant Shares issued under Clause 6.2(a) shall:

 

  (a)

be issued fully paid, free from all Encumbrances (save as set out in the Articles);

 

  (b)

rank pari passu and form one class with the fully paid shares of the same class then in issue, subject to the Articles;

 

  (c)

entitle the registered holder to receive any dividend or other distribution announced or declared on or after the date on which the Warrantholder complies with its applicable obligations in Clause 5.2; and

 

  (d)

be registered in a register of members kept outside the United Kingdom by or on behalf of the Company.

 

6.4

No fractions of a Warrant Share shall be allotted or issued on the exercise of any Subscription Entitlement and no refund will be made to the Warrantholder exercising such Subscription Entitlement with respect to such fractions. If the exercise of any Subscription Entitlement would require a fraction

 

8


  of a Warrant Share to be allotted (including but not limited to where these arise as a result of a Value Cap Warrant Shares Adjustment in accordance with Clause 9), the aggregate number of Warrant Shares so allotted to a Warrantholder will be rounded down to the nearest whole Warrant Share.

 

7.

CASH REDEMPTION

 

7.1

Where an Exercise Event has occurred or is proposed to occur, the Company may in its absolute discretion elect in the Exercise Notice relating to that Exercise Event to cancel and redeem some or all of the Subscription Entitlement attaching to the Warrants held by each Warrantholder (a Cash Redemption Election) in consideration for a payment in cash to each Warrantholder equal to either:

 

  (a)

where the Closing Price of the Class A Ordinary Shares has equalled or exceeded the Value Cap for any 20 Trading Days within the 30-Trading Day period immediately preceding:

 

  (i)

in respect of a Mandatory Exercise Event, the date of the Mandatory Exercise Event; or

 

  (ii)

in respect of a Change of Control Exercise Event, the date that the Change of Control is first announced to the market by the Company or the person or persons acquiring control in connection with the Change of Control; or

 

  (iii)

in respect of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date of the Exercise Notice,

the Value Cap multiplied by the number of Warrants held by the relevant Warrantholder in respect of which the Company has elected to redeem in cash; or

 

  (b)

where the Closing Price of the Class A Ordinary Shares has not equalled or exceeded the Value Cap for any 20 Trading Days within the 30-Trading Day period immediately preceding:

 

  (i)

in respect of a Mandatory Exercise Event, the date of the Mandatory Exercise Event; or

 

  (ii)

in respect of a Change of Control Exercise Event, the date that the Change of Control is first announced to the market by the Company or the person or persons acquiring control in connection with the Change of Control; or

 

  (iii)

in respect of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date of the Exercise Notice,

the Closing Price on the Trading Day immediately prior to the relevant date referred to in subparagraphs (i), (ii) or (iii) above (as applicable) multiplied by the number of Warrants held by the relevant Warrantholder in respect of which the Company has elected to redeem in cash (provided that if the relevant Closing Price is greater than the Value Cap, it shall be deemed to be the Value Cap),

(each such payment, a Cash Redemption Payment).

 

7.2

Where a Cash Redemption Election is made, the Subscription Entitlement (or the relevant proportion of the Subscription Entitlement, as the case may be) of a Warrantholder shall not be treated as cancelled and redeemed unless and until the Cash Redemption Payment has been made in full to the relevant Warrantholder or, if the relevant Warrantholder fails to notify the Company of its account details in accordance with Clause 5.2, to a ring-fenced bank account to be held for the benefit of the relevant Warrantholder.

 

9


7.3

Upon cancellation and redemption of the Subscription Entitlement (or the relevant proportion of the Subscription Entitlement, as the case may be) in accordance with this Clause 7, all rights and obligations of the Company and the Warrantholders in respect of the Warrants shall immediately terminate and cease to have any force or effect save for any rights which may have accrued prior to the relevant redemption.

 

8.

ADJUSTMENT OF SUBSCRIPTION ENTITLEMENT

 

8.1

If, while any Subscription Entitlement remains exercisable:

 

  (a)

there is a subdivision, consolidation, reclassification or change in nominal value (excluding a change to no par value where the number of shares in issue is otherwise unchanged) of the Class A Ordinary Shares;

 

  (b)

there is a reduction of capital (of whatever nature, but excluding a cancellation of capital that is lost or not represented by available assets), or any other reduction in the number of Equity Shares in issue from time to time;

 

  (c)

there is an issue of Equity Shares by way of dividend or distribution;

 

  (d)

there is an issue of Equity Shares by way of capitalisation of profits or reserves (including share premium account and any capital redemption reserve); or

 

  (e)

there is a consolidation, amalgamation or merger of the Company with or into another entity (other than a consolidation, amalgamation or merger following which the Company is the surviving entity and which does not result in any reclassification of, or change in, the Class A Ordinary Shares) through a share-for-share exchange or otherwise (including, for the avoidance of doubt, a merger or amalgamation where the Company is not the surviving entity),

then:

 

  (i)

the Company shall adjust the Subscription Entitlement and/or the Subscription Price conditional on any such event occurring, but with effect from the date of the relevant event or, if earlier, the record date for the event (an Adjustment), in each case, so that after such Adjustment, the total number of Warrant Shares for which the outstanding Subscription Entitlement would then be capable of being exercised carry as nearly as possible (and in any event not less than) the same proportion of the voting rights and the same entitlement (expressed as a proportion of the total entitlement conferred by all the Equity Shares) to participate in the profits and assets of the Company as if there had been no such event giving rise to the Adjustment and the Company shall procure the update of the Register accordingly; and

 

  (ii)

upon any Adjustment, the Value Cap shall be deemed to be adjusted as follows and construed accordingly (a Value Cap Adjustment):

A = (B divided by C) multiplied by D

where:

A = the adjusted Value Cap;

B = the number of Warrant Shares for which the outstanding Subscription Entitlement would be capable of being exercised immediately prior to the relevant Adjustment;

 

10


C = the number of Warrant Shares for which the outstanding Subscription Entitlement would be capable of being exercised immediately following the relevant Adjustment as determined in accordance with subparagraph (i) above; and

D = the Value Cap immediately prior to the relevant Adjustment.

 

8.2

The Company shall give the Warrantholders’ Representative written notice of any event described in Clause 8.1, together with details of the relevant Adjustment and Value Cap Adjustment and reasonable detail of any supporting calculations, at the time of, or as soon as reasonably possible after the occurrence of such event.

 

9.

ADJUSTMENT OF WARRANT SHARES

 

9.1

If in an Exercise Notice the Company elects to satisfy a Warrantholder’s Subscription Entitlement in whole or in part by way of issuing Warrant Share and the Closing Price on the Trading Day immediately prior to the relevant date as follows:

 

  (a)

in respect of a Mandatory Exercise Event, the date of the Mandatory Exercise Event; or

 

  (b)

in respect of a Change of Control Exercise Event, the date that the Change of Control is first announced to the market by the Company or the person or persons acquiring control in connection with the Change of Control; or

 

  (c)

in respect of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date of the Exercise Notice,

is equal to or exceeds the Value Cap, the number of Warrant Shares to which a Warrantholder shall be entitled per Warrant (notwithstanding and subject always to the Company’s right to elect in an Exercise Notice to redeem the Subscription Entitlement by making a Cash Redemption Payment in accordance with Clause 7) shall be adjusted downwards as follows:

A = B divided by C

where:

A = the adjusted number of Warrant Shares to which a Warrantholder is entitled per Warrant;

B = the Value Cap; and

C = the Closing Price.

 

9.2

Where applicable the Company shall notify the Warrantholders of any Value Cap Warrant Shares Adjustment in the relevant Exercise Notice and shall include reasonable detail of the calculation of such Value Cap Warrant Shares Adjustment.

 

10.

DETERMINATION BY AUDITORS OR INDEPENDENT FINANCIAL ADVISER

 

10.1

If the Warrantholders’ Representative notifies the Company in writing:

 

  (a)

within ten Business Days of receipt of a notice given under Clause 8.2 that the Warrantholder Majority disagrees with any Adjustment and/or any Value Cap Adjustment; or

 

  (b)

within five Business Days of receipt of an Exercise Notice in which the Company has notified the Warrantholders of a Value Cap Warrant Shares Adjustment that the Warrantholder Majority disagrees with such Value Cap Warrant Shares Adjustment, the Company shall refer the matter to the Auditors for determination.

 

11


10.2

In respect of any disagreement referred to the Auditors for determination pursuant to Clause 10.1:

 

  (a)

the Company and the Warrantholder(s) will each co-operate with the Auditors in resolving the disagreement as soon as reasonably possible and for that purpose will, subject to any restrictions imposed by applicable law, any regulatory authority or any obligations of confidentiality, provide to them all such information and documents as they may reasonably require;

 

  (b)

the Auditors shall have the right to seek such professional assistance and advice as they may require;

 

  (c)

the Auditors’ fees and any professional costs incurred by them shall be borne:

 

  (i)

where the Auditors’ determination in respect of the relevant matter that is the subject of the disagreement is more than 5 per cent. less or more than 5 per cent. greater than the original number or calculation proposed by the Company, by the Company; or

 

  (ii)

in all other cases, (A) 50 per cent. by the Company; and (B) 50 per cent. proportionately among the Warrantholders that disagreed with the matter (as the Warrantholders’ Representative may determine in its absolute discretion); and

 

  (d)

the Auditors shall act as experts and not as arbitrators and their decision shall (in the absence of manifest error) be final and binding on the Company and all Warrantholders.

 

10.3

If the Warrantholders’ Representative notifies the Company in writing within five Business Days of receipt of an Exercise Notice that the Warrantholder Majority disagrees with the Closing Price specified in such Exercise Notice (where applicable), the Company shall refer the matter to an Independent Financial Adviser for determination, provided that if the disputed Closing Price was first determined by an Independent Financial Adviser on behalf of the Company prior to issuing the Exercise Notice, the Company shall refer the matter to a second Independent Financial Adviser for determination.

 

10.4

In respect of any disagreement referred to an Independent Financial Adviser for determination pursuant to Clause 10.3:

 

  (a)

the Company and the Warrantholder(s) will each co-operate with the Independent Financial Adviser in resolving the disagreement as soon as reasonably possible and for that purpose will, subject to any restrictions imposed by applicable law, any regulatory authority or any obligations of confidentiality, provide to them all such information and documents as they may reasonably require;

 

  (b)

the Independent Financial Adviser shall have the right to seek such professional assistance and advice as it may require;

 

  (c)

the Independent Financial Adviser’s fees and any professional costs incurred by them shall be borne:

 

  (i)

where the Independent Financial Adviser’s determination in respect of the relevant matter that is the subject of the disagreement is more than 5 per cent. less or more than 5 per cent. greater than the original number or calculation proposed by the Company, by the Company; or

 

12


  (ii)

in all other cases, (A) 50 per cent. by the Company; and (B) 50 per cent. proportionately among the Warrantholders that disagreed with the matter (as the Warrantholders’ Representative may determine in its absolute discretion); and

 

  (d)

the Independent Financial Adviser shall act as an expert and not as an arbitrator and its decision shall (in the absence of manifest error) be final and binding on the Company and all Warrantholders.

 

11.

UNDERTAKINGS AND INFORMATION

 

11.1

For so long as any Subscription Entitlement remains exercisable, the Company shall:

 

  (a)

procure that the Board shall at all times have authority pursuant to the Articles and any applicable legal and regulatory requirements to grant Warrants and to issue Warrant Shares on exercise of any Subscription Entitlement in accordance with the terms of this Instrument and free of any Encumbrances;

 

  (b)

not permit any of the events described in Clause 8.1(a) to Clause 8.1(e) to the extent that its effect would be that, following any relevant Adjustment, on the exercise of any Subscription Entitlement the Company would be required to allot Warrant Shares at a discount to nominal value; and

 

  (c)

subject to applicable law, regulation and the rules of any applicable stock exchange, notify each Warrantholder of any anticipated Exit, or commencement of proceedings to effect a winding up in the circumstances set out in Clause 12.1, as soon as reasonably practicable after the Board becomes aware of such Exit or winding up (and, in any event, no later than five Business Days prior to completion of such Exit or passing of the resolution referred to in Clause 12.1(b), as the case may be).

 

11.2

Each Warrantholder (or agent appointed to act on its behalf) shall have the right to attend and speak (but not, by virtue of its Warrants alone, vote) at all meetings of the holders of the Class A Ordinary Shares at which any business is to be moved which will, or may reasonably be expected to, affect the value of the Warrants or the Warrant Shares or the rights attaching to any of them under this Instrument.

 

12.

WINDING UP

 

12.1

This Clause 12 applies if:

 

  (a)

any Subscription Entitlement remains unexercised; and

 

  (b)

an effective resolution for the winding up of the Company is passed for the summary (solvent) winding up of the Company under Part 21, Chapter 2 of the Law.

 

12.2

In the circumstances set out in Clause 12.1, each Warrantholder with unexercised Subscription Entitlement shall, for the purposes of ascertaining its rights in the winding up, be treated as if it had, immediately before the passing of the resolution, fully exercised its outstanding Subscription Entitlement (and, notwithstanding the time periods specified in Clause 6.1, been issued with Warrant Shares with immediate effect) and shall be entitled to receive out of the assets available in the liquidation pari passu with the holders of the Class A Ordinary Shares (or other Warrant Shares as may be required following an Adjustment) such sum as it would have received had it been the holder of all such Class A Ordinary Shares (or such other Warrant Shares as may be required following an Adjustment) to which it would have been entitled by virtue of that exercise after deducting a sum equal to the sum which would have been payable for Warrant Shares, but nothing in this Clause 12 shall require a Warrantholder to make any payment to the Company or any other person.

 

13


13.

TRANSFER OF WARRANTS

The provisions of paragraph 2 of Schedule 4 shall govern the transfer of Warrants.

 

14.

MEETINGS OF WARRANTHOLDERS

All resolutions and consents of the Warrantholders shall be adopted by way of Warrantholder Consent. Nevertheless, if a meeting of the Warrantholders is to be held, all the provisions of the Articles and any applicable statutory requirements relating to general meetings shall apply to that meeting as if:

 

  (a)

the Warrants constituted shares in the capital of the Company; and

 

  (b)

each Warrantholder was a member of the Company,

provided that the quorum for such a meeting shall be such number of Warrantholders present in person, by proxy or by authorised representative holding 50% in nominal amount of the Warrant Shares subject to outstanding Warrants on the date of the meeting.

 

15.

WARRANTHOLDERS’ REPRESENTATIVE

 

15.1

The Warrantholders’ Representative shall be entitled to carry out the functions conferred on it by this agreement.

 

15.2

The Warrantholders’ Representative shall not be liable to any Warrantholder for any act or omission in connection with the performance by the Warrantholders’ Representative (in that capacity) of its duties, functions and/or role pursuant to this Instrument, except in the case of its fraud or dishonesty. The Warrantholders’ Representative may act upon any instrument or written communication believed by the Warrantholders’ Representative to be genuine and to be signed and presented by the proper person(s). Each of the Warrantholders hereby undertakes to indemnify and keep indemnified and hold harmless the Warrantholders’ Representative from all losses, costs, damages, expenses (including professional fees) and any other liabilities that may be incurred by the Warrantholders’ Representative (in that capacity) as a result of performance of its duties, functions and role as the Warrantholders’ Representative under this agreement provided that the Warrantholders’ Representative shall not be entitled to indemnification for and in respect of any matter where its actions or inactions are fraudulent or dishonest.

 

15.3

Any consent given in accordance with the provisions of this Instrument by the Warrantholders’ Representative in connection with this Instrument shall bind all the Warrantholders.

 

16.

TAX

All payments by the Company under this Instrument shall be made free and clear of any Tax Deduction, unless such withholding or deduction is required by law. In the event of a Tax Deduction being made by the Company in respect of a payment made by it, the Company shall pay such additional amounts as will result in the receipt by the Warrantholders, after any withholding or deduction for or on account of such taxes, duties, assessments or charges, of such amounts as would have been received by them if no such Tax Deduction had been required.

 

17.

PAYMENTS

 

17.1

Unless otherwise expressly stated (or as otherwise agreed in the case of a given payment), each payment to be made to the Company and to a Warrantholder under this Instrument or in respect of any Warrant shall be made in US dollars by transfer of the relevant amount into the relevant account on the date (and, if applicable, at or before the time) the payment is due for value on that date and in immediately available funds.    

 

14


17.2

The relevant account for a given payment to the Company is:

 

  bank:    Barclays Bank PLC
  sort code:    20-36-47
  account number:    53060166
  account name:    BHL Fundraising USD
  SWIFT:    BARCGB22
  IBAN:    GB34BARC20364753060166

or such other US dollar account in the name of the Company as shall be: (i) notified to the Warrantholders’ Representative not less than three Business Days before the date that payment is due for the purpose of that payment; and (ii) approved by the Warrantholders’ Representative following the Company’s compliance with anti-money laundering requirements to the satisfaction of the Warrantholders.

 

17.3

The relevant account for a given payment to a Warrantholder is the US dollar account specified by the Warrantholder (or the Warrantholders’ Representative on its behalf), not less than three Business Days before the date that payment is due, by giving notice to the Company in accordance with Clause 21 for the purposes of that payment. In the absence of any such notice the relevant payment shall be made to a ring-fenced bank account and held for the benefit of the relevant Warrantholder.

 

18.

VARIATION

 

18.1

Subject to Clause 8 and Clause 18.2, no variation or abrogation of the terms of this Instrument or of all or any of the rights for the time being attached to the Warrants shall be effective (whether or not the Company is being wound up) without Warrantholder Consent. Any such variation or abrogation shall be effected by way of deed poll executed by the Company and expressed to be supplemental to this Instrument.

 

18.2

Modifications to this Instrument which are of a minor or administrative nature only, and have no impact on the rights and obligations under this Instrument, may be effected by way of deed poll executed by the Company and expressed to be supplemental to this Instrument.

 

18.3

The Company shall, within five Business Days of making any variation pursuant to this Clause 18, send to each Warrantholder (or, in the case of joint holders, to the Warrantholder named first in the Register) a copy of the deed poll (or other document) effecting the variation.

 

19.

SEVERANCE

If any provision or part-provision of this Instrument is or becomes invalid, illegal or unenforceable, it shall be deemed modified to the minimum extent necessary to make it valid, legal and enforceable. If such modification is not possible, the relevant provision or part-provision shall be deemed deleted. Any modification to or deletion of a provision or part-provision under this Clause 19 shall not affect the validity and enforceability of the rest of this Instrument.

 

20.

THIRD PARTY RIGHTS

 

20.1

Except as expressly provided in Clause 20.2, a person who is not a party to this Instrument shall not have any rights under the Contracts (Rights of Third Parties) Act 1999 or otherwise to enforce any term of this Instrument.

 

20.2

The provisions of this Instrument are intended to confer rights and benefits on the Warrantholders and the Warrantholders’ Representative and such rights and benefits shall be enforceable by each of them to the fullest extent permitted by law.

 

15


20.3

The Company undertakes that it will duly observe and perform the obligations on its part contained in this Instrument and the Warrants shall be issued and held subject to and with the benefit of the provisions of this Instrument.

 

21.

NOTICES

Any notice to be given to or by any Warrantholder(s) for the purposes of this Instrument shall be given in accordance with the provisions of paragraph 4 of Schedule 4.

 

22.

GOVERNING LAW AND JURISDICTION

 

22.1

This Instrument and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with English law.

 

22.2

Each party irrevocably agrees that the English courts shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this Instrument or its subject matter or formation (including non-contractual disputes or claims).

 

23.

PROCESS AGENT

 

23.1

Without prejudice to any other mode of service allowed under any relevant law, the Company:

 

  (a)

irrevocably appoints Babylon Partners Limited with registered number 08493276, the registered office of which is at 1 Knightsbridge Green, London, England, SW1X 7QA as its agent for service of process in relation to any proceedings before the English courts in connection with this Instrument; and

 

  (b)

agrees that failure by an agent for service of process to notify the Company of the process will not invalidate the proceedings concerned.

 

23.2

If any person appointed as an agent for service of process is unable for any reason to act as agent for service of process, the Company shall immediately (and in any event within five days of such event taking place) appoint another agent on terms acceptable to the Warrantholders’ Representative. Failing this, the Warrantholders’ Representative may appoint another agent for this purpose.

THIS DEED has been entered into on the date stated at the beginning of it.

 

16


SCHEDULE 1

INITIAL WARRANTHOLDERS

 

Name

  

Address

  

E-mail Address

   Number of Warrants
AlbaCore Partners II Investment Holdings D Designated Activity Company    10 Earlsfort Terrace, Dublin, Dublin, D02 T380, Ireland (copy to: 55 St James’s Street, London, SW1A 1LA)    Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and legal@albacorecapital.com)    509,675
AlbaCore Partners III Investment Holdings Designated Activity Company    10 Earlsfort Terrace, Dublin, Dublin, D02 T380, Ireland (copy to: 55 St James’s Street, London, SW1A 1LA)    Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and legal@albacorecapital.com)    1,203,887
AlbaCore Strategic Investments LP    Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (copy to: 55 St James’s Street, London, SW1A 1LA)    Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and legal@albacorecapital.com)    43,937

 

17


SCHEDULE 2

FORM OF WARRANT CERTIFICATE

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE.    

WARRANT CERTIFICATE NO. [__]

BABYLON HOLDINGS LIMITED

a public limited company incorporated and registered in Jersey

registered number: 115471

registered office: [13 Castle Street, St Helier, Jersey, JE1 1ES]

(the Company)

 

Date of issue:

  

[●]

Warrantholder name:

  

[●]

Registered address:

  

[●]

Principal place of business:

  

[●]

THIS IS TO CERTIFY that the person named above is the registered holder of [●] Warrants, which entitle the Warrantholder to subscribe for Warrant Shares at the Subscription Price on the terms and subject to the conditions set out in the warrant instrument issued by the Company on [●] 2021 (the Instrument), subject to the Articles.

This certificate is issued with the benefit of, and subject to, the terms of the Instrument, a copy of which is available on request from the Company. The Warrants represented by this certificate and the Subscription Entitlement relating to such Warrants are not transferable except in accordance with the Instrument. Terms defined in the Instrument have the same meaning when used in this certificate.    

 

EXECUTED as a DEED and DELIVERED by

      )          

BABYLON HOLDINGS LIMITED

      )                       

acting by a duly authorised director

      )          

in the presence of:

      )       

 

  

Witness Signature:

 

 

    

Witness Name:

 

 

    

Witness Address:

 

 

    

 

    

    

    

Witness Occupation:

 

 

    

 

18


SCHEDULE 3

FORM OF EXERCISE NOTICE

 

  

The Directors

Babylon Holdings Limited

13 Castle Street

St Helier

Jersey JE1 1ES

To:

Warrantholders’ Representative

By e-mail to: [●]

[DATE]

We refer to the warrant instrument dated [●] 2021 (the Instrument) issued by Babylon Holdings Limited. Terms defined in the Instrument have the same meanings when used in this Exercise Notice.

We hereby give notice of [details of Exercise Event], which constitutes a[n] [Mandatory Exercise Event][Early Redemption Exercise Event][Change of Control Exercise Event][Final Maturity Exercise Event] for the purposes of the Instrument.

For the purposes of clause 5.1 of the Instrument:

 

1.

the Subscription Entitlement [was][shall be] deemed to be automatically and irrevocably exercised on [date] [at [time]];

 

2.

the Company will satisfy the aggregate Subscription Entitlement by [issuing an aggregate number of [●] Warrant Shares [and]][making an aggregate Cash Redemption Payment of [●] [(net of deduction of an aggregate Subscription Price of US$[●] in respect of the number of Warrant Shares to be issued (rounded up to the nearest US$0.01)]];

 

3.

the [Warrant Shares [and]][Cash Redemption Payment shall be allocated among the Warrantholders as set out in the Schedule to this Exercise Notice;

 

4.

the Exercise Completion Date shall be [date];

 

5.

[the number of Warrant Shares to be issued to the Warrantholders on the Exercise Completion Date as set out in paragraph 2 and the Schedule to this Exercise Notice has been subject to a Value Cap Warrant Shares Adjustment calculated as follows: [reasonable detail to be included];]

 

6.

[the Cash Redemption Payment to be made to the Warrantholders on the Exercise Completion Date as set out in paragraph 2 and the Schedule to this Exercise Notice has been calculated as follows: [reasonable detail to be included]; [and]

 

7.

[the [Closing Price] for the purposes of the calculations referred to in paragraph[s] [●] above [has][have] been determined as follows [reasonable detail to be included].

We hereby request that each Warrantholder complies with its obligations pursuant to Clause 5.2 of the Instrument within the applicable time period specified therein.

 

19


Signed by [NAME OF DIRECTOR] for and on behalf of Babylon Holdings Limited          

 

[SIGNATURE OF DIRECTOR]

  
     Director   

SCHEDULE TO EXERCISE NOTICE

[Details of allocation of Warrant Shares and/or Cash Redemption Payment among Warrantholders to be included]

 

20


SCHEDULE 4

THE CONDITIONS

 

1.

THE REGISTER AND CERTIFICATES

 

1.1

The Register shall be kept and maintained at the Registered Office or at such other place (at all times outside the United Kingdom) as the Company may from time to time determine and notify to the Warrantholders and there shall promptly be entered in the Register:

 

  (a)

the names and addresses of the Warrantholders, supplied in accordance with paragraph 4 of this Schedule 4;

 

  (b)

the number of Warrants held by each Warrantholder;

 

  (c)

the date on which each person was registered as a Warrantholder, in respect of each tranche of Warrants held by it;

 

  (d)

the date on which the Subscription Entitlement was exercised and the number of Warrants for which such Subscription Entitlement was exercised;

 

  (e)

the date on which any person ceased to be a Warrantholder;

 

  (f)

updates arising out of Adjustments in accordance with Clause 8.1; and

 

  (g)

all transfers of the Warrants.

 

1.2

The Company shall promptly amend the Register after receiving notice of a change in a Warrantholder’s details for service pursuant to paragraph 4.4 of this Schedule 4.

 

1.3

The Warrantholders or any of them, or any person authorised by a Warrantholder, shall be at liberty at all reasonable times during office hours to inspect the Register and to take copies of or extracts from it or any part of it.

 

1.4

The Company shall be entitled to treat each person named in the Register as a Warrantholder as the absolute owner of a Warrant and, accordingly, shall not, except as ordered by a court of competent jurisdiction or as required by law, be bound to recognise any equitable or other claim to or interest in a Warrant on the part of any other person, whether or not it shall have express or other notice of such a claim.

 

1.5

Every Warrantholder shall be recognised by the Company as entitled to its Warrants free from any equity, set-off or cross-claim against the original or an intermediate holder of such Warrants.

 

1.6

Each Warrantholder shall be issued with a Certificate (together with a copy of this Instrument and, at the Warrantholder’s request, a copy of any other document referred to in this Instrument) promptly and, in any event, within ten Business Days, following:

 

  (a)

the date on which it is registered as a Warrantholder; and

 

  (b)

any Adjustment (except where such Adjustment is referred to the Auditors for determination in accordance with Clause 10, in which case, following completion of the Auditors’ determination).

 

1.7

If a Certificate is mutilated, defaced, lost, stolen or destroyed, it will be replaced by the Company upon payment by the claimant of such reasonable costs as may be incurred in connection with such replacement and on such terms as to evidence and indemnity as the Company may reasonably require. Mutilated or defaced Certificates must be surrendered before replacements will be issued.

 

21


2.

TRANSFER OF WARRANTS

 

2.1

No Warrantholder shall assign, transfer, mortgage, charge, declare a trust over, or deal in any other manner with its Warrants or any of its rights in respect of the Warrants (each such transaction, a Transfer) without the express prior written approval of the Board (such approval to be given in the absolute discretion of the Board), other than:

 

  (a)

to a Permitted Transferee of the Warrantholder; or

 

  (b)

where a Transfer of Notes is permitted pursuant to the terms of the Notes Deed Poll,

in each case, provided that a Transfer of Notes is made simultaneously to the same person and the number of Warrants the subject of the Transfer is equal to the Equivalent Proportion.

 

2.2

Subject to paragraph 2.1, Warrants may be transferred by means of (and only by means of) an instrument of transfer in any usual form or any other form approved by the Board acting reasonably.

 

2.3

An instrument of transfer shall be made under hand and executed by or on behalf of the transferor but need not be signed by the transferee. The transferor shall be deemed to remain the holder of the Warrants until the name of the transferee is entered in the Register for the Warrants being transferred.

 

2.4

The Board may refuse to register a transfer unless such instrument is deposited at the Registered Office together with any Certificate(s) issued by the Company in respect of such Warrants (or deed of indemnity in favour of the Company on such terms as the Company may reasonably require in the case of any lost, damaged or destroyed Certificates) and such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer.

 

2.5

The registration of a transfer shall be conclusive evidence of approval by the Board of the transfer.

 

2.6

No fee shall be charged for the registration of a transfer of a Warrant, or for the registration of any other documents which, in the opinion of the Board, require registration.

 

2.7

Any transfer of a Warrant purported to be made otherwise than in accordance with this paragraph 2 shall be void and have no effect.

 

3.

CONFIDENTIALITY

 

3.1

A Warrantholder shall not at any time disclose to any person the existence of or contents of this Instrument, or any confidential information concerning the business, affairs, customers, clients or suppliers of the Group, except as permitted by paragraph 3.2.

 

3.2

A Warrantholder may disclose information, where such disclosure would otherwise be prohibited under paragraph 3.1 if and to the extent:

 

  (a)

the information is or becomes publicly available (other than by breach of this Instrument by the Warrantholder);

 

  (b)

the Company has given prior approval to the disclosure or use;

 

  (c)

the information is information about the Group which the board of directors of the Company has confirmed in writing to a Warrantholder is not confidential;

 

22


  (d)

the information is independently developed by a Warrantholder after the date of this Instrument;

 

  (e)

the disclosure or use is required by legal or regulatory requirements, any governmental or regulatory body or any stock exchange on which the shares of a Warrantholder or any of its Associated Companies is listed (including where this is required as part of any actual or potential offering, placing and/or sale of securities of that Warrantholder or any of its Associated Companies) or requested by any court of competent jurisdiction or any relevant governmental, judicial, supervisory, regulatory or self-regulatory body;

 

  (f)

the disclosure or use is required for the purpose of any judicial proceedings arising out of this Instrument or any documents to be entered pursuant to it;

 

  (g)

the disclosure of information is to any tax authority to the extent such disclosure is reasonably required for the purposes of the tax affairs of a Warrantholder or any of its Associated Companies;

 

  (h)

provided that in the event that any demand or request for disclosure of such information is made pursuant to paragraph 3.2(e) to (g) above, such Warrantholder shall (to the extent reasonably practicable to do so and, further, subject to such notification not being in breach of any applicable confidentiality obligations) promptly notify the Company of the existence of such request or demand and shall provide the Company with a reasonable opportunity to seek an appropriate protective order or other remedy, which both the Warrantholders and Company will cooperate in seeking to obtain. In the event that such appropriate protective order or other remedy is not obtained, the Warrantholder shall furnish, or cause to be furnished, only that portion of the confidential information that is legally required to be disclosed;

 

  (i)

the disclosure by a Warrantholder or its Associated Companies is to any of its Associated Companies, Related Funds and any of its or their officers, directors, employees, professional advisers, auditors, partners and representatives and is in respect of such information as such Warrantholder or such Associated Companies shall consider reasonably appropriate, provided that any person to whom the information is to be given pursuant to this paragraph 3.2(i) is informed in writing of its confidential nature and that some or all of such information may be price-sensitive information provided further that that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to such information;

 

  (j)

the disclosure of information is on a confidential basis to any bona fide proposed transferee of Warrants (including any Permitted Transferee, third party, professional advisers, auditors, insurers or financiers of such party) wishing to acquire Warrants from a Warrantholder in accordance with the terms of this Instrument to the extent that any such persons need to know the information for the purposes of considering, evaluating, advising on or furthering the potential purchase, or to service providers and professional advisors who in their ordinary course of carrying out their services for such Warrantholder or its Associated Companies may come into contact with confidential information and who are bound by an obligation of confidentiality to such Warrantholder or is otherwise subject to professional obligations to maintain the confidentiality of the information; and

 

  (k)

the disclosure is to:

 

  (i)

another Warrantholder; and

 

  (ii)

the Warrantholders’ Representative.

 

 

23


3.3

No Warrantholder shall use any confidential information relating to the Group for any purpose other than to perform its obligations, or to exercise its rights, under this Instrument.

 

4.

NOTICES

 

4.1

For the purposes of this paragraph 4, but subject to paragraph 4.7, notice includes any other communication.

 

4.2

Unless otherwise specified in this Instrument, a notice given to a party under or in connection with this Instrument:

 

  (a)

shall be in writing and in English;

 

  (b)

shall be sent by e-mail (unless a delivery failure message is received by the sender, in which case it may be sent to the registered address of the recipient by another method referred to in paragraph 4.5(b)):

 

  (i)

in the case of the Company, to legal-corporate@babylonhealth.com (marked for the attention of the General Counsel);

 

  (ii)

in the case of the Initial Warrantholders, to the Warrantholders’ Representative at Ipeer@albacorecapital.com and legal@albacorecapital.com (marked for the attention of Itay Peer and Joe Ohlson), or such other e-mail address or person as that person may notify to the Company in accordance with the provisions of this paragraph 4; and

 

  (iii)

in the case of any Warrantholder (other than the Initial Warrantholders) to such e-mail address or person as that Warrantholder shall notify to the Company in accordance with the provisions of this paragraph; and

 

  (c)

unless proved otherwise, is deemed received as set out in paragraph 4.5.

 

4.3

Each Warrantholder (other than an Initial Warrantholder) shall register with the Company an e-mail address to which notices can be sent and, if such Warrantholder fails to do so, notice may be given to that Warrantholder by sending the same by any of the methods referred to in paragraph 4.2 to the last known e-mail address of such Warrantholder or, if none, by sending such notice to the Warrantholders’ Representative.

 

4.4

A Warrantholder may change its details for service of notices by giving notice to the Company following any change. Any change notified under this paragraph 4.4 shall take effect at 9am (London time) on the later of:

 

  (a)

the date (if any) specified in the notice as the effective date for the change; or

 

  (b)

five Business Days after deemed receipt of the notice.

 

4.5

Delivery or receipt (as the case may be) of a notice is deemed to have taken place (if all other requirements in this paragraph 4 have been satisfied):

 

  (a)

if sent by e-mail, at the time of transmission (provided that no delivery failure message is received by the sender); or

 

  (b)

where a delivery failure message is received by the sender:

 

  (i)

if delivered by hand, on signature of a delivery receipt or at the time the notice is left at the address;

 

24


  (ii)

if sent by pre-paid first class post, recorded delivery or special delivery to an address in the United Kingdom, at 9am on the second Business Day after posting; or

 

  (iii)

if sent by reputable international overnight courier to an address outside the country from which it is sent, on signature of a delivery receipt or at the time the notice is left at the address.

If deemed receipt under the previous sub-paragraphs of this paragraph 4.5 would occur outside business hours (meaning 9am to 5.30pm Monday to Friday on a day that is not a public holiday in the place of deemed receipt), at 9am on the day when business next starts in the place of deemed receipt. For the purposes of this paragraph 4.5, all references to time are to local time in the place of deemed receipt.

 

4.6

To prove service, it is sufficient to prove that:

 

  (a)

if delivered by hand or by reputable international overnight courier, the notice was delivered to the correct address;

 

  (b)

if sent by e-mail, a transmission report was received confirming that the notice was successfully transmitted to the correct e-mail address; or

 

  (c)

if sent by post, the envelope containing the notice was properly addressed, paid for and posted.

 

4.7

This paragraph 4 does not apply to the service of any proceedings or other documents in any legal action or, where applicable, any arbitration or other method of dispute resolution.

 

4.8

All notices with respect to Warrants registered in the names of joint holders shall be given to whichever of such persons is named first in the Register and any notice so given shall be sufficient notice to all the joint registered holders of such Warrants.

 

4.9

Any person who, whether by operation of law, transfer or other means whatsoever, becomes entitled to any Warrant, shall be bound by every notice properly given to the person from whom it derives title to such Warrant.

 

4.10

When a given number of days’ notice must be given, the day of service shall be included but the day on which such notice shall expire shall not be included in calculating the number of days. The signature to any notice to be given by the Company may be written or printed.

 

25


SIGNATORIES

EXECUTED as a DEED by

BABYLON HOLDINGS LIMITED

 

By:  
Name:   Ali Parsadoust
Title:   Director
By:  
Name:   Mairi Johnson
Title:   Director

 

26


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/17/23  Babylon Holdings Ltd.             POS AM                 3:521K                                   Toppan Merrill/FA
 3/16/23  Babylon Holdings Ltd.             10-K       12/31/22  142:69M
11/29/22  Babylon Holdings Ltd.             POS AM                 3:571K                                   Toppan Merrill/FA
 5/20/22  Babylon Holdings Ltd.             F-4                  229:36M                                    Toppan Merrill/FA
 4/29/22  Babylon Holdings Ltd.             F-1                  158:21M                                    Toppan Merrill/FA
 4/28/22  Babylon Holdings Ltd.             POS AM               155:21M                                    Toppan Merrill/FA
 3/30/22  Babylon Holdings Ltd.             20-F       12/31/21  166:22M
 3/30/22  Babylon Holdings Ltd.             424B3                  1:4.4M                                   Toppan Merrill/FA


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/27/21  Babylon Holdings Ltd.             F-4/A                  5:7.9M                                   Donnelley … Solutions/FA
 9/15/21  Babylon Holdings Ltd.             F-4/A                 18:9.6M                                   Donnelley … Solutions/FA
 8/09/21  Babylon Holdings Ltd.             F-4/A       8/06/21    5:11M                                    Donnelley … Solutions/FA
 7/02/21  Babylon Holdings Ltd.             F-4                    8:6.4M                                   Donnelley … Solutions/FA
 6/04/21  Alkuri Global Acquisition Corp.   8-K:1,7,9   6/03/21   13:22M                                    Toppan Merrill/FA
Top
Filing Submission 0001193125-21-324433   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 6:21:54.2pm ET